Claim
The study tested selected synthetic promoters in primary human CD8-positive T cells and characterized an NR4A2-responsive subset in vitro and in tumor-infiltrating engineered T cells in a melanoma xenograft model.
30 words; atomic claims are usually under 25a conjunction joins clauses that may be separately evaluableTopics
Assessment
Supported
Main unresolved issue: 3 counted evidence items have no independence review; repeats of one origin may be counted as several coverage:233fa232-5523-8a55-9809-b420b249122a
Not yet independently audited.Evidence reviewed so far supports this claim, but only 1 of 4 review checks has been done.
Why?
Strongest counted support: The primary study reports seven TF-responsive promoter classes and testing in primary CD8 T cells plus a melanoma xenograft model. weight 1.800000 evidence
Suppressed as dependent: The quoted passage directly reports testing synthetic promoters in primary human CD8 T cells and characterizing NR4A2-responsive promoters in melanoma xenograft T cells.
Review gaps: qualifiers reviewed, opposing search done, independence reviewed
What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Unresolved.
0.8581 under ledger-default@0.3.0 at snapshot 27745 · state Supported · Review checks: 1 of 4 · stability MEDIUM · 3 sources, 1 independent lineage
How the number was reached
| Link | Working | Weight | Counted as |
|---|---|---|---|
| b54c0b68 qualify | relevance DIRECT 2.0 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 0.000000 (non directional) |
| 43955d4f support | relevance DIRECT 2.0 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 0.000000 (dependent strongest only, kept bf1e4398) |
| bf1e4398 support | relevance DIRECT 2.0 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 1.800000 |
prior 0.50 → log-odds 0.000000 + 1.800000 (the counted weights) = 1.800000 → probability 0.8581
Your view
Registered views
Nobody has registered a view yet.
Checked as part of
- “A Nature Communications study developed synthetic promoters responsive to T-cell transcription factors and tested selected promoters in primary CD8 T cells...” · 2 claims · 29 September 2026
Evidence for
-
From A modular synthetic promoter toolkit for programmable gene control in activated and chronically stimulated T cells Read 2026-09-29 Relevance DIRECT Steps 0 Counted
The abstract directly reports tests in primary CD8 T cells and engineered T cells in melanoma xenografts.
-
From A modular synthetic promoter toolkit for programmable gene control in activated and chronically stimulated T cells Read 2026-09-29 Relevance DIRECT Steps 0 Counted
The excerpt states both experimental systems and the NR4A2-responsive subset.
Evidence against
None.
Qualifications
-
From A modular synthetic promoter toolkit for programmable gene control in activated and chronically stimulated T cells Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Limits cell populations, assay settings, model system, and clinical generalization.
Suppressed as dependent
| Evidence | Group | Kept instead |
|---|---|---|
| e911b39b | bf1e4398 |
Inferences
Concluded from
None.
Used as a premise in
None.
Threads
None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.
Claim edges
| From | Relationship | To |
|---|---|---|
| 4c76c1ad | NARROWS | b249122a |
Review checklist
Review checks: 1 of 4
| Check | Done | By |
|---|---|---|
| qualifiers reviewed | no | |
| opposing search done | no | |
| independence reviewed | no | |
| primary source reviewed | yes | b54c0b68, 43955d4f, bf1e4398 |
Summary
Supported. The main support is: The primary study reports seven TF-responsive promoter classes and testing in primary CD8 T cells plus a melanoma xenograft model. 86cf3f92
1 further item repeats the same origin and is not independent evidence. e911b39b
Qualifier: The study used HEK293 and Jurkat cell lines, primary human CD8 T cells, in-vitro assays, and a melanoma xenograft model. b9dd9acf
A narrower version of this claim is supported. 4c76c1ad
Review checks: 1 of 4. coverage:233fa232-5523-8a55-9809-b420b249122a
Contribution history
| seq | event | detail |
|---|---|---|
| 21754 | APPENDED | |
| 21755 | ACCEPT | AUTOMATIC_AFTER_VALIDATION |
| 21762 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 24565 | TASK_RESULT | by 1efd24fe (accepted) |
| 25626 | TASK_RESULT | by 1efd24fe (accepted) |
Score trace
{
"claim": "233fa232-5523-8a55-9809-b420b249122a",
"links": [
{
"link": "1810685a-6e74-82e2-92fc-50d6b54c0b68",
"group": null,
"reason": "non_directional",
"edition": "NAMED_OR_UNRELATED",
"evidence": "2037c925-0c5f-87f0-8632-55a4b9dd9acf",
"direction": "QUALIFY",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "0.000000",
"interpretive_steps": 0
},
{
"kept": "a4144c4c-5cfb-8e05-a69b-3cb1bf1e4398",
"link": "532c423f-4e41-8f94-97ac-d4ce43955d4f",
"group": null,
"reason": "dependent_strongest_only",
"edition": "NAMED_OR_UNRELATED",
"evidence": "634d0456-2a17-86c5-bc94-aeede911b39b",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "0.000000",
"interpretive_steps": 0
},
{
"link": "a4144c4c-5cfb-8e05-a69b-3cb1bf1e4398",
"group": null,
"edition": "NAMED_OR_UNRELATED",
"evidence": "dd388139-d65f-8307-8206-47a786cf3f92",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.800000",
"interpretive_steps": 0
}
],
"model": "ledger-default@0.3.0",
"prior": "0.50",
"variants": {
"spread": "0.1331",
"permissive": "0.9121",
"conservative": "0.7790"
},
"code_hash": "sha256:c61a6fdf35a754a0d7e958df149036a083c0eaeb7d2d2e52704ec32b0c36def7",
"contested": false,
"stability": "MEDIUM",
"claim_type": "OBSERVATIONAL",
"config_hash": "sha256:86768038080b8ab5233f1e4b7aba10af05b5bb44caa432095150b90e81209809",
"probability": "0.8581",
"provisional": true,
"evidence_sum": "1.800000",
"snapshot_seq": 25627,
"prior_log_odds": "0.000000",
"support_groups": 1,
"model_dependent": false,
"review_coverage": "0.25",
"truth_evaluable": true,
"assessment_state": "SUPPORTED",
"review_checklist": {
"qualifiers_reviewed": {
"by": [],
"ok": false
},
"opposing_search_done": {
"by": [],
"ok": false
},
"independence_reviewed": {
"by": [],
"ok": false
},
"primary_source_reviewed": {
"by": [
"1810685a-6e74-82e2-92fc-50d6b54c0b68",
"532c423f-4e41-8f94-97ac-d4ce43955d4f",
"a4144c4c-5cfb-8e05-a69b-3cb1bf1e4398"
],
"ok": true
}
},
"contradict_groups": 0,
"rounding_boundary": false,
"posterior_log_odds": "1.800000",
"not_applicable_reason": null,
"independence_unreviewed": 3
}